---

Dexmedetomidine versus Lignocaine for extubation in patients undergoing craniotomies

Full Text PDF

---

Original Article

Author Details : Safneedha , S Vishwanath*

Volume : 8, Issue : 2, Year : 2021

Article Page : 326-330

https://doi.org/10.18231/j.ijca.2021.060

Suggest article by email

Get Permission

Abstract

Background: Use of lignocaine and dexmedetomidine in terms of causing hemodymaic variation, sedation and pain management remains a question. Hence this was conducted to compare a bolus dose of dexmedetomidine 0.5mcg/kg/hr to a normal dose of 1.5mg/kg preservative free 2% lignocaine for extubation in patients undergoing craniotomies.
Materials and Methods: This randomized controlled trial was conducted in the department of Anesthesiology at Sri Ramachandra Medical College and Research Institute, Chennai from January 2013 to June 2014. Patients aged between 18-60 years belongs to ASA class I and class II undergoing surgeries were included in the study. A total of fifty cases were included. Statistical analysis was done using SPSS version 17.
Results: Hemodynamic parameters showed significant attenuation of hemodynamic response during extubation when compared to lignocaine group and when the same were analyzed within the groups, the attenuation of extubation response was both clinically and statistically significant in both groups. Extubation and emergence time were similar in both the groups. Sedation and pain scores in dexmedetomidine group were low compared to lignocaine group.
Conclusion: Single dose of dexmedetomidine given 10 minutes before extubation significantly attenuated the hemodynamic and airway response following extubation as compared to lignocaine given before reversal in patients undergoing craniotomy for intracranial space occupying lesions.

Keywords: Dexmedetomidine, Lignocaine, Craniotomy, Space occupying lesions.

How to cite : Safneedha, Vishwanath S , Dexmedetomidine versus Lignocaine for extubation in patients undergoing craniotomies. Indian J Clin Anaesth 2021;8(2):326-330

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.